These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9571329)

  • 1. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.
    Desfaits AC; Serri O; Renier G
    Diabetes Care; 1998 Apr; 21(4):487-93. PubMed ID: 9571329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging.
    Renier G; Mamputu JC; Desfaits AC; Serri O
    J Diabetes Complications; 2003; 17(2 Suppl):20-9. PubMed ID: 12623165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gliclazide on monocyte-endothelium interactions in diabetes.
    Renier G; Desfaits AC; Serri O
    J Diabetes Complications; 2000; 14(4):215-23. PubMed ID: 11004431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte modulation of endothelial leukocyte adhesion molecules.
    Weill D; Wautier JL; Dosquet C; Wautier MP; Carreno MP; Boval B
    J Lab Clin Med; 1995 Jun; 125(6):768-74. PubMed ID: 7539477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.
    Devaraj S; Jialal I
    Circulation; 2000 Jul; 102(2):191-6. PubMed ID: 10889130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin.
    Desfaits AC; Serri O; Renier G
    Diabetes Obes Metab; 1999 Mar; 1(2):113-20. PubMed ID: 11220509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.
    Papanas N; Tziakas D; Chalikias G; Floros D; Trypsianis G; Papadopoulou E; Kortsaris A; Symeonidis G; Souliou E; Maltezos E; Hatseras D
    Diabetes Metab; 2006 Sep; 32(4):344-9. PubMed ID: 16977262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.
    Renier G; Mamputu JC; Serri O
    Metabolism; 2003 Aug; 52(8 Suppl 1):13-8. PubMed ID: 12939734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes.
    Mohamed-Ali V; Armstrong L; Clarke D; Bolton CH; Pinkney JH
    J Intern Med; 2001 Nov; 250(5):415-21. PubMed ID: 11887976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus.
    Ohno Y; Aoki N; Nishimura A
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1072-7. PubMed ID: 8408455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium.
    Renier G; Desfaits AC; Serri O
    Metabolism; 2000 Feb; 49(2 Suppl 1):17-22. PubMed ID: 10693915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL.
    Desfaits AC; Serri O; Renier G
    Metabolism; 1997 Oct; 46(10):1150-6. PubMed ID: 9322798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of adhesion molecule expression on endothelial cells after induction by lipopolysaccharide-stimulated whole blood.
    Nooteboom A; van der Linden CJ; Hendriks T
    Scand J Immunol; 2004 May; 59(5):440-8. PubMed ID: 15140053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
    Cipollone F; Chiarelli F; Davì G; Ferri C; Desideri G; Fazia M; Iezzi A; Santilli F; Pini B; Cuccurullo C; Tumini S; Del Ponte A; Santucci A; Cuccurullo F; Mezzetti A
    Diabetologia; 2005 Jun; 48(6):1216-24. PubMed ID: 15868137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.
    Albertini JP; Valensi P; Lormeau B; Aurousseau MH; Ferrière F; Attali JR; Gattegno L
    Diabetes Care; 1998 Jun; 21(6):1008-13. PubMed ID: 9614623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1.
    Cid MC; Kleinman HK; Grant DS; Schnaper HW; Fauci AS; Hoffman GS
    J Clin Invest; 1994 Jan; 93(1):17-25. PubMed ID: 7506711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor necrosis factor-alpha with anti-diabetic agents.
    Fukuzawa M; Satoh J; Qiang X; Miyaguchi S; Sakata Y; Nakazawa T; Ikehata F; Ohta S; Toyota T
    Diabetes Res Clin Pract; 1999 Mar; 43(3):147-54. PubMed ID: 10369423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide stimulates monocyte adherence by effects on both the monocyte and the endothelial cell.
    Doherty DE; Zagarella L; Henson PM; Worthen GS
    J Immunol; 1989 Dec; 143(11):3673-9. PubMed ID: 2511247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.
    Serri O; St-Jacques P; Sartippour M; Renier G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):58-63. PubMed ID: 9920062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.